SScalp MicrobiomeSeborrheic DermatitisSensitive SkinSkin AgeingSkin & MaternitySkin & OncologySkin & PollutionSkin BarrierSkin LesionsSkin MicrobiomeSkin of Color
VVitiligo
XXerosis(DrySkin)
Discover scientific content related to skin and hair care through different formats - articles, videos, expert interviews, publications, clinical studies, etc...Become a member
Professional Development
Continuing Medical EducationTraining
Professional development will help you test your knowledge and stay up to date on research & science on skin and hair careBecome a member
Practice Resources
HomepageProfessional ResourcesPatient Resources
Practice ressources will aid you in your daily practice of dermatologyBecome a member
Events
Event ReportsUpcoming events
Browse our database of past and upcoming dermatology events and assetsBecome a member
About us
Who we areWhat we care aboutContact us
We empower each and everyone with the most advances skincare management. Our brands offer a range of skincare and haircare products to respond to all expectations linked to beauty and skin health. From skin pathologies and aesthetic concerns and from the most accessible ranges to the most premium ones.Become a member
Discovery of 2-Mercaptonicotinoyl Glycine. A new potent brightening agent for hyperpigmentation management, exhibiting a low environmental impact.
A. Prévot Guéguiniat, P. Sextius, G. Lereaux, E. Warrick, S. Ben Hassine, L. Baux, J. Qiu, S. Grégoire, S. Ito, K. Wakamatsu, J. Xu, X. Marat
Jul 2023
10min
INTRODUCTION
Research of brightening agents is an important but difficult task due to multi parameter considerations. An innovative methodolo gy is described, based notably on high throughput screening test (HTS), in silico method predicting physico chemical properties and environmental profile , and highly physiologic pigmented biological models, which led to the discovery of 2 mercaptonicotinoyl glycine (2 MNG). Their capacity to inhibit melanin production via top ical application on 3D pigmented reconstructed epidermis was superior to 4 n butylresorcinol, a tyrosinase inhibitor chosen as a reference on the market.